Goforth v. Bristol-Myers Squibb Company et al
Filing
11
CONDITIONAL TRANSFER ORDER (CTO-1) directing the Clerk of Court to transfer this case to the Eastern District of Kentucky as part of MDL No. 2809. Signed by the Clerk of the Panel, Jeffery N. Luthi on 2/15/2018. (mef)
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION
IN RE: ONGLYZA (SAXAGLIPTIN) AND
KOMBIGLYZE XR (SAXAGLIPTIN AND
METFORMIN) PRODUCTS LIABILITY
LITIGATION
MDL No. 2809
(SEE ATTACHED SCHEDULE)
CONDITIONAL TRANSFER ORDER (CTO −1)
On February 2, 2018, the Panel transferred 39 civil action(s) to the United States District Court for
the Eastern District of Kentucky for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2018). Since that time, no additional action(s) have been
transferred to the Eastern District of Kentucky. With the consent of that court, all such actions have
been assigned to the Honorable Karen K Caldwell.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Kentucky and assigned to
Judge Caldwell.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Kentucky for the reasons stated in the order of February 2, 2018, and, with the
consent of that court, assigned to the Honorable Karen K Caldwell.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Kentucky. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.
FOR THE PANEL:
Feb 13, 2018
Jeffery N. Lüthi
Clerk of the Panel
FILED AND CERTIFIED
ROBERT R. CARR, CLERK
U.S. DISTRICT COURT
EASTERN DISTRICT OF KENTUCKY
Date:
By:
Deputy Clerk
IN RE: ONGLYZA (SAXAGLIPTIN) AND
KOMBIGLYZE XR (SAXAGLIPTIN AND
METFORMIN) PRODUCTS LIABILITY
LITIGATION
MDL No. 2809
SCHEDULE CTO−1 − TAG−ALONG ACTIONS
DIST
DIV.
C.A.NO.
CASE CAPTION
17−02024
17−02056
Hardy v. Bristol−Myers Squibb Company et al
Lacy v. Bristol−Meyers Squibb Company et al
17−00736
Goforth v. Bristol−Myers Squibb Company et al
3
17−03110
Veloria v. Bristol−Myers Squibb Company et al
1
17−02798
Driver v. Bristol−Meyers Squibb Company et al
17−02095
Garcia v. Bristol−Myers Squibb Company et al
17−00860
MASK v. BRISTOL−MYERS SQUIBB COMPANY et
al
17−24379
Holmes v. Astrazeneca Pharmaceuticals LP et al
17−04342
17−04934
17−00155
Green v. Bristol−Myers Squibb Company et al
Harris v. Bristol−Myers Squibb Company et al
Nance v. Brystol−Myers Squibb Company et al
ALABAMA NORTHERN
ALN
ALN
2
7
ARKANSAS EASTERN
ARE
4
ARKANSAS WESTERN
ARW
COLORADO
CO
FLORIDA MIDDLE
FLM
6
FLORIDA NORTHERN
FLN
3
FLORIDA SOUTHERN
FLS
1
GEORGIA NORTHERN
GAN
GAN
GAN
1
1
3
GAN
GAN
3
3
17−00156
17−00157
Merritt v. Bristol−Myers Squibb Company et al
Hayes v. Bristol−Myers Squibb Company et al
18−01015
Adams v. Bristol−Myers Squibb Company et al
17−00207
BEELER v. BRISTOL−MYERS SQUIBB COMPANY
et al
17−00180
Barner v. Bristol−Myers Squibb Company et al
17−12986
Jones v. Bristol−Myers Squibb Company, et al
3
6
17−01535
17−01501
Winborne v. Bristol−Myers Squibb Co et al
Sandoval v. Bristol−Myers Squibb Co et al
1
17−02974
Ellis v. Bristol−Myers Squibb Company et al
ILLINOIS CENTRAL
ILC
1
INDIANA SOUTHERN
INS
4
KENTUCKY WESTERN
KYW
5
LOUISIANA EASTERN
LAE
2
LOUISIANA WESTERN
LAW
LAW
MARYLAND
MD
MISSISSIPPI NORTHERN
MSN
1
17−00207
Stacy v. Bristol−Myers Squibb Company et al
17−02867
Turner v. Bristol−Myers Squibb Company et al
2
18−04001
Lyles v. Bristol−Myers Squibb Company, et al
NJ
3
17−03027
NJ
3
17−03031
NJ
3
17−04533
WOODS v. BRISTOL MEYERS SQUIBB COMPANY
et al
WILLIAMS v. BRISTOL MYERS SQUIBB
COMPANY et al
JOHNSON v. BRISTOL−MEYERS SQUIBB
COMPANY et al
18−00190
Caldwell v. Bristol−Myers Squibb Company, et al
MISSOURI EASTERN
MOE
4
MISSOURI WESTERN
MOW
NEW JERSEY
OHIO NORTHERN
OHN
3
OHN
OHN
4
5
17−02573
17−02333
Campbell v. Bristol−Myers Squibb Company et al
Dinger Sr. v. Bristol−Myers Squibb Company et al
17−00409
McCall v. Bristol−Myers Squibb Company et al
17−03167
17−03297
Winkle v. Bristol−Myers Squibb Company et al
Epps v. Bristol−Myers Squibb Company et al
17−02808
17−02810
17−02812
Jackson v. Bristol−Myers Squibb Company et al
Silvers v. Bristol−Myers Squibb Company et al
Word v. Bristol−Myers Squibb Company et al
17−03028
17−00888
17−00253
17−00278
Carter v. Bristol−Myers Squibb Company et al
Davis v. Bristol−Myers Squibb Company et al
Rosencranse v. Bristol−Myers Squibb Company et al
Lynn v. Bristol−Myers Squibb Company et al
4
17−03321
Slaughter v. Bristol−Myers Squibb Company et al
1
17−00179
Medley v. Bristol−Myers Squibb Company et al
OKLAHOMA EASTERN
OKE
6
SOUTH CAROLINA
SC
SC
2
4
TENNESSEE WESTERN
TNW
TNW
TNW
2
2
2
TEXAS NORTHERN
TXN
TXN
TXN
TXN
3
4
5
5
TEXAS SOUTHERN
TXS
UTAH
UT
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?